BPMC's hCG patent challenged by Kaiser; BPMC seeking royalties of $3-$9 per prenatal test.
This article was originally published in The Gray Sheet
Executive Summary
BPMC'S hCG PATENT CHALLENGED BY KAISER PERMANENTE complaint filed in the U.S. District Court for northern California on Aug. 28. Kaiser maintains that a patent received by Biomedical Patent Management Corp. principal Mark Bogart is not infringed by the "triple marker" test widely used for diagnosis of birth defects in pregnant women, according to the six-page suit. Bogart's patent, #4,874,693, was issued in 1989.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.